Markets:

Overview

News

Currencies

International

Treasuries

Abbott Laboratories (NY:ABT)

112.68 +1.21 (+1.09%)

Official Closing Price Updated: 7:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

53 54 Next >

Abbott Labs Q1 Revenue Jumps On Strong Medical Devices Sales, Company Boosts Annual Guidance ↗

April 17, 2024

Abbott Laboratories surpasses expectations with Q1 sales hitting $9.96B, a 10.8% rise driven by robust performance in Medical Devices, Established Pharmaceuticals, Nutrition, and Diagnostics. CEO...

Via Benzinga

Wall Street Poised To Rebound From Slump As Earnings Optimism Grows: Analyst Eyes This S&P 500 Level As Attractive Entry Point ↗

April 17, 2024

U.S. stocks are priming for a firmer start on Wednesday, potentially striving to inflect higher from the weakness seen so far in April. As some bullish market watchers pointed out there could be an...

Via Benzinga

Topics Stocks

Earnings Scheduled For April 17, 2024 ↗

April 17, 2024

Companies Reporting Before The Bell • ASML Holding (NASDAQ:ASML) is projected to report quarterly earnings at $3.43 per share on revenue of $6.13 billion.

Via Benzinga

Abbott Laboratories Dividend Stock Analysis ↗

April 12, 2024

Abbott Laboratories discovers, develops, manufactures, and sells healthcare products. Its products include branded generic pharmaceuticals manufactured internationally, marketed, and sold outside the...

Via Talk Markets

Abbott Laboratories Unusual Options Activity ↗

April 11, 2024

Via Benzinga

Investor Optimism Decreases; Dow Ends 6-Session Losing Streak ↗

April 17, 2024

The CNN Money Fear and Greed index showed a decline in the overall market sentiment, with the index remaining in the "Fear" zone on Tuesday. U.S. stocks closed mixed on Tuesday amid increased...

Via Benzinga

Topics Stocks

Abbott Laboratories, U.S. Bancorp And 3 Stocks To Watch Heading Into Wednesday ↗

April 17, 2024

With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Johnson & Johnson is as Cheap as it’s Going to Get

April 16, 2024

Johnson & Johnson raised its dividend for the 62nd consecutive year and has the power to continue raising the annual payout indefinitely.

Via MarketBeat

Healthcare Stocks Are Lagging With Big Earnings Weeks Ahead ↗

April 16, 2024

Healthcare stocks disappointed again last week with the XLV down over 3% and up only 1.65 % YTD, in a continued downtrend since March 28.

Via Talk Markets

Analyst Ratings For Abbott Laboratories ↗

April 03, 2024

Via Benzinga

How Is The Market Feeling About Abbott Laboratories? ↗

March 28, 2024

Via Benzinga

Performance Comparison: Abbott Laboratories And Competitors In Health Care Equipment & Supplies Industry ↗

March 27, 2024

Via Benzinga

3 Buy Rated Stocks To Consider As Earnings Approach ↗

April 13, 2024

With the Q1 earnings season underway, there will be a microscope on companies that can continue to show improvements in their outlook amid an uptick in inflation.

Via Talk Markets

Jim Cramer Calls Cummins 'Terrific,' Recommends Selling This Chinese Auto Manufacturer ↗

April 12, 2024

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes New Fortress Energy Inc.

Via Benzinga

Why Wall Street Got Even More Excited About The Glucose Monitor — And How Dexcom, Abbott Labs Stand To Benefit ↗

April 12, 2024

Continuous glucose monitors have spiked in popularity since the advent of weight-loss drugs. Is chronic disease at its end?

Via Investor's Business Daily

Got $200? 2 Healthcare Stocks to Buy and Hold Forever. ↗

April 11, 2024

These companies provide stability, reliability, and passive income.

Via The Motley Fool

7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape ↗

April 10, 2024

Although the market may be grumbling over certain issues, concerned investors can trust these healthcare stocks to deliver the goods.

Via InvestorPlace

Jim Cramer Was Upset At This Hostile Takeover, But 'They Fixed The Situation. Stock's Been A Horse' ↗

April 09, 2024

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he prefers Abbott Laboratories (NYSE: ABT) over

Via Benzinga

3 Dividend Growth Stocks With Yields Above 3% That You Can Buy and Hold for the Next Decade ↗

April 09, 2024

Income-seeking investors can look forward to steady payout raises from these pharma stocks.

Via The Motley Fool

3 Top Dividend Stocks to Buy in April 2024 ↗

April 06, 2024

Each of these high-quality stocks looks like a buy.

Via The Motley Fool

Top Analyst Reports For T-Mobile US, Abbott Laboratories & Palo Alto Networks ↗

April 06, 2024

Today's Research Daily features new research reports on 16 major stocks, including T-Mobile US, Inc. (TMUS), Abbott Laboratories (ABT) and Palo Alto Networks, Inc. (PANW).

Via Talk Markets

FDA Approves Abbott's Heart Valve Repair Device For Patients At Risk Of Complications/Death During Open-Heart Surgeries ↗

April 02, 2024

FDA approves Abbott Laboratories' TriClip TEER system for treating tricuspid regurgitation. Clip technology offers non-invasive repair, fast recovery, and significant improvement in quality of life....

Via Benzinga

DexCom Stock Gains from GLP-1 Diabetic Users

April 02, 2024

DexCom Inc. (NASDAQ: DXCM) is a leading medical device company in the medical sector that specializes in continuous glucose monitoring (CGM) systems. People

Via MarketBeat

Russell 2000 Index Best And Worst Performing Stocks Of 2024 ↗

April 02, 2024

The Russell 2000 index continued to underperform the Dow Jones and Nasdaq 100 indices in the first quarter of 2024.

Via Talk Markets

Topics Stocks

3 Strong Buy Healthcare Stocks to Add to Your Q2 Must-Watch List ↗

March 29, 2024

In an aging world, strong buy healthcare stocks like UNH, ABT, and MRK shine with dividends, innovation, and market growth.

Via InvestorPlace

Winning Over Wall Street: 3 Stocks Earning Overwhelming Analyst Approval ↗

March 26, 2024

Discover the investment potential of three stocks with analyst approval for their robust financials and strategic market positions.

Via InvestorPlace

More Than 86% of Analysts Who Cover These 3 Stocks Rate Them a ‘Buy’ ↗

March 25, 2024

Investors should take notice of these stocks with high analyst ratings. It's time to load up your portfolio.

Via InvestorPlace

Want Decades of Passive Income? 2 Stocks to Buy Now. ↗

March 22, 2024

There aren't many guarantees in the equity market, but the dividend payouts of Johnson & Johnson and Abbott Laboratories may be as close as it gets to a sure thing.

Via The Motley Fool

3 Stocks to Buy Right Now for the Coming Recession ↗

March 21, 2024

With numerous economic indicators souring, these three stocks to buy for a recession will protect your portfolio's downside.

Via InvestorPlace

Topics Economy

3 Resilient Stocks to Protect Your Wealth During a Recession ↗

March 21, 2024

Discover three recession-resistant stocks with growth leads in the consumer staples, household products, and healthcare industries.

Via InvestorPlace

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

53 54 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Abbott Laboratories (NY:ABT)

All News about Abbott Laboratories

Starting at $3.75/week.

Subscribe Today